Search Results

Présence régionale Apprendre encore plus Notre Projets Ceci est votre page de projet. C'est une excellente occasion d'aider les visiteurs à comprendre le contexte et l'arrière-plan de votre dernier travail. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez partager. Partner with us nom du projet Voici la description de votre projet. Fournissez un bref résumé pour aider les visiteurs à comprendre le contexte et l'arrière-plan de votre travail. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. View More nom du projet Ceci est la description de votre projet. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. View More nom du projet Ceci est la description de votre projet. Fournissez un bref résumé pour aider les visiteurs à comprendre le contexte et l'arrière-plan de votre travail. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. View More Regulatory Support AcedrA is your go-to for Regulatory Support in the MENA region. Our team of experienced professionals provides Regulatory Approval services that are tailored to each need and requirement, allowing them to bring their pharmaceutical & medical products to market quickly and efficiently. View More Business Support With an experienced team of professionals, AcedrA provides tailor-made services that allow clients to optimize their processes and operations. Our solutions are designed to lower costs, improve efficiency, and maximize Return On Investment. View More Enhancing our Capabilities is in our DNA Develop Smartly We are a fast-growing startup with continuous improvement of our capabilities and expanding our footprint. Partner with AcedrA today to live this amazing journey of success! Business Development Advisory & Consultancy Regional Presence

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton for the Scientific Communities At AcedrA, we provide the scientific communities in the MENA region with access to cutting-edge technologies such as CRISPR/Cas9, CAR-T cell therapy, stem cell technology, enzyme replacement therapies, antibody-drug conjugates, and more. Our team of experienced professionals is dedicated to helping scientific and medical communities to access innovative treatments and therapies that improve the lives of people in the MENA region. We are committed to delivering quality products and services that enable researchers and medical professionals to unlock their potential for success. By leveraging our expertise in innovative technologies, we can empower scientists and healthcare professionals with the tools they need to drive progress in medical research. We believe that with our help, the MENA region can become a hub for scientific breakthroughs and advancements. We strive to bring the latest, safest and most advanced technologies to the region and ensure that our clients have access to the resources they need. At AcedrA, we are proud of our commitment to serve both the scientific community and local communities in the MENA region. We believe that through collaboration with healthcare professionals, researchers, clinicians, governments and organisations, we can create a positive future for everyone. With our help, the region has the potential to become an innovation powerhouse for medical research and development. We invite you to join us on our mission to drive progress in medical research and support the scientific communities in MENA. Through our dedication to providing innovative technologies, CRISPR-Cas9 "Clustered Regularly Interspaced Short Palindromic Repeats - CRISPR Associated Protein 9" It is a gene editing technology that has revolutionized the field of biotechnology. It uses a bacterial enzyme, CAS9, which can be programmed to recognize and cut specific sequences of DNA. This allows for the precise editing of genes without damaging surrounding cells. It can be used to treat a variety of diseases including cancer, HIV, and inherited genetic disorders. Stem Cells Stem cells are an important tool in medical research and therapy. They are able to differentiate into specialized cell types, offering potential treatments for a variety of diseases. Stem cell therapy has been used in the treatment of cancer, Parkinson's disease, spinal cord injuries, and other conditions. The cells can be harvested from adult tissue or derived from induced pluripotent stem cells, which are reprogrammed adult cells. In addition to their use in treating human disease, stem cells have been used to create disease models and study pathogenesis CAR-T "Chimeric Antigen Receptor - T Cell Receptor" It is a form of immunotherapy that involves the modification of a patient’s own T cells to recognize and fight existing cancer or other diseases. In this form of treatment, a patient's T cells are collected from their blood and modified in the laboratory with special receptors known as chimeric antigen receptors (CARs). The modified T cells, now known as CAR-T cells, are then reinfused into the patient's body. Protein Targeted Protein-targeted therapeutics is a type of molecular medicine that focuses on targeting specific proteins in the body to treat diseases. By selectively blocking, modulating, or activating certain proteins, these therapies can affect biological pathways and lead to therapeutic benefits. This is useful for treating chronic conditions such as cancer, autoimmune diseases, and neurological disorders. Examples include monoclonal antibodies, protein-based small molecules, aptamers, and engineered proteins known as fusion proteins. RNA Targeted RNA-targeted therapeutics provide a promising approach that can help address the limitations of existing treatments. Currently, there are two main types of RNA-targeted therapies being developed: small interfering RNAs (siRNAs) and messenger RNA activators (mRNAs). siRNAs are short pieces of double-stranded RNA that selectively silence genes, while mRNAs directly upregulate gene expression. Both approaches have the potential to revolutionize the treatment of a variety of diseases, including genetic disorders and cancer. Biosimilars Biosimilars or Biobetters are biological therapies that are developed to be highly similar, though not identical, to an already referenced drug. As they are produced by a different manufacturer than the originator of the reference drug, they must undergo comprehensive analytical and clinical studies in order to prove safety, quality, and efficacy with comparable characteristics to their reference drug. Following regulatory approval, biosimilars can be used to treat a wide range of diseases, enabling wider access to treatments for patients at lower costs. Academia, Researchers At AcedrA we understand that the challenge of advancing medical treatments is a complex one. We are committed to helping researchers and academia to find new opportunities through which they can leverage innovative therapies to bridge this gap Contact Us for Healthcare Professionals AcedrA is an innovative platform designed to bridge the gap between healthcare professionals and unmet medical needs. Our platform enables healthcare providers to quickly analyze patient data to identify potential treatments or therapies that can address a patient's specific medical condition. This powerful tool allows healthcare professionals to make informed decisions about treatment strategies, helping them provide better care for their patients. AcedrA also provides insights into unmet medical needs, allowing healthcare professionals to identify areas of potential intervention and make more impactful decisions. By leveraging the power of data and analytics, AcedrA is empowering healthcare providers to deliver personalized patient care that meets their individual needs. With our platform, healthcare providers can provide quality care with confidence and provide optimal outcomes for their patients. Named Patient Programs Compassionate Use Patient Safety Pre-Approved Medicines Product Inquiry Conitnuous Learning Comparator Sourcing Medical Training Clinical Supply Unlicensed Medicines Transparency & Disclosure We recognize that patients expect transparency around these relationships to feel confident that HCPs are impartial and always recommend the most appropriate treatment options. The payments and transfers of value disclosed here were made for activities such as providing professional advice about how medicines are used in practice, sharing professional expertise at medical education meetings, and taking part in advisory boards, research, and educational grants: Transparency Healthcare Professionals AcedrA is also dedicated to providing access to the latest medical research and treatments. Our extensive database of resources allows healthcare professionals to stay up-to-date with the most recent advancements in medical treatments and therapies, helping them make informed decisions about patient care. Additionally, our platform offers data-driven insights that allow healthcare providers to identify trends and patterns in patient care, allowing them to make more informed decisions about treatment strategies Contact Us for Individual Patients AcedrA is an innovative medical technology company helping individual patients with unmet medical needs. Our proprietary technologies and processes allow us to develop and implement personalized treatments for conditions that have no approved therapies. We are dedicated to improving the lives of patients with serious diseases, giving them a solution when other traditional methods have failed. Our team of medical professionals and researchers is committed to finding solutions to complex clinical problems with our cutting-edge technologies. We are continually developing new treatments and approaches that can help patients who have exhausted all other possibilities. Our dedication to patient care means we strive to provide the best possible outcomes, while also addressing any concerns or questions they may have. Patient Safety Product Inquiry Individual Patients If you are an individual patient or visiting this site on behalf of a patient who suffers from an unmet medical need, please contact your healthcare provider (e.g. doctor, pharmacist, or hospital). AcedrA, once contacted by your healthcare provider, will discuss the options for gaining access to the requested therapy. Contact Us for Patient Advocacy Groups Our team is dedicated to providing high-quality patient support and services. We are continuously working to improve our existing products and develop new solutions that meet the needs of our partners’ patients. By doing so, we remain committed to bettering the lives of those who need it most. We believe that no patient should be left behind—everyone deserves access to the best care available. We look forward to working with our partners and patient advocacy groups to advance healthcare solutions and make a positive impact on patients regionally. We strive to provide our partners and customers with high-quality medical solutions that best meet the unique needs of their patients. To achieve this, we regularly evaluate patient feedback collected from patient advocacy groups and other relevant sources to ensure our products and services always meet their needs. We also use the insights gathered to inform our research and development initiatives, ensuring that all new products are designed with patient needs in mind. By doing so, we can continuously improve our offerings and provide optimal solutions to best suit our partners’ patient base. Our goal is to ensure that all patients have access to the best possible medical care and treatments. Patient Safety Product Inquiry Compassionate Use Patient Advocacy Groups We are proud to be working with a patient advocacy group whose mission is to empower people living with unmet medical needs. Through this partnership, AcedrA has been able to provide patients access to the most advanced technology and resources available. Our collaboration with the patient advocacy group means that we are able to offer a range of innovative solutions for those living with unmet medical needs, giving them more control over their health outcomes and quality of life. We are excited to see the positive impact this partnership will have on all those involved. Together, we can make a difference in the lives of those living with unmet medical needs! Contact Us for Corporates Bi otec h, Pharma, MedTech AcedrA's MSLs offer comprehensive medical affairs services to pharmaceutical, biotechnology, and medical technology companies. Our MSL team is composed of experienced medical advisors and MSLs, who have a deep understanding of all areas of the industry and provide insights into the ever-changing regulatory landscape. MSLs are experts in their field, providing a comprehensive range of medical affairs services, including scientific exchange and market access. Our MSLs create and implement tailored strategies that fit the needs of each company, helping them to maximize revenues while maintaining compliance with industry regulations. By utilizing our MSLs’ expertise, clients can improve their product positioning in the marketplace and gain visibility amongst key stakeholders. MSLs also provide support in areas such as product launches, medical education, promotional campaigns, and publications. AcedrA's MSLs are dedicated to providing our customers with the highest level of medical affairs services possible. Product Inquiry Compassionate Use Named Patient Programs Pre-Approved Medicines Comparator Sourcing Clinical Supply Unlicensed Medicines Biotechnology Pharmaceutical Medical Tech By leveraging the expertise and experience of our MSL team, pharmaceutical, biotechnology, and medical technology companies can be confident in the quality of their medical affairs services. We are dedicated to providing our customers with the best possible solutions for their needs. With AcedrA, you can trust that your MSL team will provide reliable, comprehensive medical affairs services tailored to meet each and every one of your business’s requirements. Let us show you the difference AcedrA MSLs can make Contact Us AcedrA Pharmacovigilance System Patient Safety Or call AcedrA Pharmacovigilance Hotline KSA: 8001240411 (Toll-Free) | International: +966 11 400 0036 AcedrA's pharmacovigilance system is designed to help protect patient safety. Our team of qualified professionals quickly identifies any potential risks and takes the necessary steps to prevent harm to patients. We have established robust processes for data collection, analysis, and reporting in order to ensure accurate risk assessments and informed decisions. Additionally, our dedicated teams continually review and monitor our pharmacovigilance system to ensure its effectiveness. With AcedrA's comprehensive pharmacovigilance system, you can rest assured that your patients are always in safe hands. Regulatory Support Business Support

Nous contacter Vous pouvez choisir de nous contacter par sujet ou d'utiliser notre formulaire général. Contacter par sujet Arabie Saoudite Le siège social Tél : +966 11 400 0036 | +966 11 400 0032 Télécopie : +966 11 400 0059 E-mail:info@acedrarx.com Entrepôt Entrepôt central logistique à Riyad, Arabie Saoudite Tél : +966 11 400 0036 Télécopie : +966 11 400 0059 E-mail:logistique@acedrarx.com Carrières Pour postuler à un emploi, envoyez un e-mail à :human.resources@acedrarx.com Pour en savoir plus sur l'environnement de travail chez AcedrA, écrivez-nous àLIFE@acedrarx.com Pour postuler à des programmes de stages, veuillez nous écrire àstages@acedrarx.com Pour une demande générale, tél. : +966 11 400 0032 Développement des affaires Pour les opportunités d'affaires,business.development@acedrarx.com Pour les licences :licence@acedrarx.com Pour les programmes d'accès anticipé :EAP@acedrarx.com Pour des prestations personnalisées :services@acedrarx.com Pour les appels d'offres et les ventes institutionnelles :sales@acedrarx.com Pour les produits enregistrés :marketing@acedrarx.com Médias Pour les présentations et rapports d'entreprise :finance@acedrarx.com À des fins médiatiques :media@acedrarx.com Pour en savoir plus sur l'environnement à AcedrA : LIFE@acedrarx.com Qualité Pour les problèmes de qualité généraux :quality@acedrarx.com Pour les problèmes de qualité liés aux processus d'exploitation :operations@acedrarx.com Pour les problèmes de qualité liés à l'un de nos produits (promus ou distribués) :pharmacovigilance@acedrarx.com Tunisie Bureau de Tunis, pour les demandes de la région Afrique du Nord Tél. Télécopie : +216 70 287 207 E-mail:info.tunisie@acedrarx.com Sécurité du patient Si vous soupçonnez ou rencontrez un événement indésirable suite à l'administration de l'un de nos produits (promus ou distribués), veuillez appeler : Hotline AcedrA Pharmacovigilance :+966 55 490 8087 ou écrivez un email à:pharmacovigilance@acedrarx.com ou alorscliquez ici pour être redirigé vers la section sécurité des patients Affaires réglementaires Direction des Affaires Réglementaires Tél. Télécopie : +966 11 400 0059 E-mail:Regulatory.affairs@acedrarx.com Fournisseurs et approvisionnement Pour la facturation et la facturation :finance@acedrarx.com Pour l'approvisionnement :approvisionnement@acedrarx.com pour les demandes de produits :business.support@acedrarx.com Pour les demandes de processus :operations@acedrarx.com Pour les problèmes de qualité :quality@acedrarx.com Pour les demandes générales, tél. : +966 11 400 0036 RSE Pour les nouvelles et les mises à jour d'AcedrA sur la responsabilité sociale des entreprises : media@acedrarx.com Pour participer à nos activités RSE en tant que bénévole :LIFE@acedrarx.com pour les demandes générales, tél. : +966 11 400 0036 Conformité Tél : +966 11 400 0036 Pour les problèmes de conformité ou les rapports :compliance@acedrarx.com Emirats Arabes Unis Bureau de Dubaï, pour les demandes de renseignements sur les fournisseurs de services : Tél :+971 4 454 2345 Télécopie : +971 4 454 2368 E-mail:info.uae@acedrarx.com Professionnels de la santé Pour les professionnels de santé Tél : +966 11 400 0036 Pour les affaires médicales, écrivez à :medical.affairs@acedrarx.com Pour les programmes d'accès anticipé (programmes de patients nommés, utilisation compassionnelle, approvisionnement clinique), envoyez un courriel à :EAP@acedrarx.com Demandes de produits Si vous êtes un professionnel de la santé, envoyez un courriel à :medical.affairs@acedrarx.com Pour information publique, envoyez un courriel à :info@acedrarx.com Si vous êtes un partenaire, un client ou un fournisseur, envoyez un e-mail :business.support@acedrarx.com Pour une demande générale, la ligne d'assistance téléphonique d'informations médicales AcedrA :+966 55 490 8087 Investisseurs Pour les informations financières et les relations bancaires :finance@acedrarx.com Pour les opportunités d'investissement d'entreprise :invest@acedrarx.com Pour les opportunités d'affaires :business.development@acedrarx.com Pour une demande générale, tél. : +966 11 400 0032 Gouvernance Pour laisser un commentaire ou une suggestion, envoyez un courriel à :compliance@acedrarx.com Pour entrer en contact avec nos instances de gouvernance : Secrétaire du Conseil d'Administration :BOD@acedrarx.com Secrétaire du Conseil de Conformité :BOC@acedrarx.com Secrétaire du Conseil Scientifique :BSA@acedrarx.com Pour postuler en tant que membre du conseil d'administration :invest@acedrarx.com Amélioration continue Si vous avez des suggestions, des idées ou des réclamations, n'hésitez pas à nous contacter Vous êtes salarié (anonyme) :LIFE@acedrarx.com Vous êtes un tiers externe :business.support@acedrarx.com Forme générale Prénom Nom de famille E-mail Code Téléphone fixe Société Sujet Écrire un message Téléverser un fichier Téléchargez le fichier pris en charge (Max 15 Mo) Nous faire parvenir Merci d'avoir soumis ! Locations Home

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Section titre Chaque site Web a une histoire et vos visiteurs veulent entendre la vôtre. Cet espace est une excellente occasion de donner un aperçu complet de qui vous êtes, de ce que fait votre équipe et de ce que votre site a à offrir. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez que les visiteurs du site connaissent. Si vous êtes une entreprise, parlez de vos débuts et partagez votre parcours professionnel. Expliquez vos valeurs fondamentales, votre engagement envers les clients et comment vous vous démarquez de la foule. Ajoutez une photo, une galerie ou une vidéo pour encore plus d'engagement. Investors Newsroom

Conseil d'administration d'Acedra Les conseils d'administration d'AcedrA sont chargés de fixer des objectifs et de développer des pratiques éthiques pour assurer la conformité aux réglementations gouvernementales, améliorer le service à la clientèle et favoriser une croissance positive continue de l'entreprise. Les membres du conseil d'administration d'Acedra discutent des stratégies, fixent des objectifs à long terme, fournissent des conseils sur les activités opérationnelles, approuvent les acquisitions et les investissements, identifient les problèmes de personnel clés, autorisent les transactions ou projets majeurs et approuvent les états financiers. Le conseil d'administration d'AcedrA est considéré comme de précieux contrevenants qui relient les administrateurs et la haute direction aux parties prenantes ; créer de la transparence dans la performance de l'entreprise ; rédiger des politiques d'entreprise; surveiller les risques; assurer le respect des lois; processus d'examen; renforcer la confiance des actionnaires ; et stimuler l'innovation. Bkhit Al Dosari Président du Conseil Homme d'affaires expérimenté et ouvert d'esprit avec différentes organisations dans plusieurs secteurs. Membre du conseil d'administration d'une grande entreprise de construction. Hosni STA Fondateur & PDG Pharmacien de formation, entrepreneur avec une expertise régionale dans l'établissement de modèles commerciaux réussis dans les secteurs biotechnologique et pharmaceutique. Mesfer Al Dosari Co-fondateur et directeur général Homme d'affaires avisé avec une grande connaissance des écosystèmes en Arabie Saoudite. Membre du conseil d'administration de plusieurs entreprises dans diverses spécialités. Avez-vous un message à notre BoD, écrivez-nous et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Corporate Social Responsibility Executive Team

AcedrA Terms & Conditions of Business 1. DEFINITIONS Within these conditions the following definitions shall apply: "AcedrA" shall mean AcedrA Pharmaceutical Company LLC and any AcedrA Subsidiary (as applicable). “AcedrA Subsidiary” shall mean any person that directly or indirectly is controlled by AcedrA Pharmaceutical Company LLC. “Controlled by” shall mean the power to direct or cause the direction of the management or policies of a person whether through the direct or indirect ownership of voting securities, by contract, resolution, regulation, or otherwise. "Deliverables" shall mean all documents, products, and materials developed by the Supplier or its agents, contractors, and employees as part of or in relation to the Services in any form or media. "Intellectual Property Rights" shall mean patents, rights to inventions, copyright and related rights, moral rights, trademarks and service marks, business names, and domain names, rights in get-up and trade dress, goodwill and the right to sue for passing off, rights in designs, rights in computer software, database rights, rights to use, and protect the confidentiality of, confidential information (including know-how and trade secrets), and all other intellectual property rights, in each case whether registered or unregistered and including all applications and rights to apply for and be granted, renewals or extensions of, and rights to claim priority from, such rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world. "Order" shall mean the authorized Purchase Order placed by AcedrA upon the Supplier for goods and/or services, including the conditions detailed herein and any authorized amendment thereto. "Products" shall mean all goods to be supplied under the Order, and any replaced or repaired goods provided by the Supplier pursuant to an Order. “Sanctions Laws” means any law, regulation, or wider measure applicable to either AcedrA or the Supplier relating to the adoption, implementation, and enforcement of economic sanctions, export controls, and trade embargos. “Sanctioned Person” means any individual, entity, or body (i) specifically designated under Sanctions Laws, (ii) owned or controlled by any individual, entity, or body specifically designated or listed under Sanctions Laws, or (iii) acting for or on behalf of any individual, entity or body specifically designated or listed under Sanctions Laws. "Services" shall mean all services to be supplied under the Order. "Supplier" shall mean the contracting party on whom the Order is placed. "Working Days" shall mean a day, other than a Friday, Saturday, or public holiday in Saudi Arabia when banks in Saudi Arabia are open for business. And, shall mean a day, other than Saturday, Sunday, or public holiday outside in Saudi Arabia when banks outside Saudi Arabia are open for business. 2. APPLICABLE CONDITIONS These conditions and the Order shall constitute the entire agreement between the parties and shall supersede any prior communications or representations between the parties except that in the event of any conflict between these conditions and the Order and any signed agreement between the parties, the signed agreement shall take precedence. By accepting AcedrA's Order the Supplier agrees that these conditions and the Order supersede any Conditions of Sale issued by the Supplier. All of these conditions shall apply to the supply of both Products and Services except where the application to one or the other is specified. 3. OFFICIAL ORDER No Products or Services will be accepted or paid for unless supplied in accordance with the Order. The Supplier shall reference the Order number on all correspondence entered into. Within 2 Working Days of the Order being issued, the Supplier shall sign and return a copy of the Order to confirm its acceptance. Failure to comply will result in the Order being deemed as accepted. The Supplier shall not deliver the Products in installments without AcedrA's prior written consent. Prior to accepting the Order, the Supplier will inform AcedrA if the Products must be delivered in installments and AcedrA can consent at its discretion. Where it is agreed that the Products are to be delivered in installments, they may be invoiced and paid for separately. 4. AMENDMENTS Prior to acceptance of the Order by the Supplier in accordance with clause 3, AcedrA may amend or withdraw its Order at any time. Once accepted, no variation to the Order will be recognized by AcedrA unless presented in writing and duly authorized by AcedrA in writing. 5. SPECIFICATION Once an Order is accepted by the Supplier in accordance with clause 3, all Products or Services under each Order shall conform where applicable with the quantity, quality, standard, and specification stated on the Order. All Products shall comply with all applicable statutory and regulatory requirements relating to the manufacture of the Products and shall be of satisfactory quality (within the meaning of the Saudi Food and Drug Authority Clearance Conditions & Requirements 2015 , as amended) and fit for the purpose made known to the Supplier by AcedrA expressly or by implication and free from defect whether actual or latent. Where the Supplier has provided AcedrA with a sample of the Products, the Products delivered will be of the same quality as the sample and be without defect. All Products must comply with Saudi Food and Drug Authority Regulatory Framework for Drugs Approval 2020 in order to minimize the risk of transmitting animal spongiform encephalopathy via Medical Products. All New Products ordered by AcedrA require documentation from the manufacturer confirming compliance with the Saudi Food and Drug Authority Clearance Conditions & Requirements 2015. All Products must have at least Sixty Seven Percent (67%) (2/3) of shelf life remaining as of the date of delivery to AcedrA. Failure to comply will result in non-payment unless a prior agreement has been reached with AcedrA. In the event of a product recall, the Supplier shall reimburse AcedrA for all reasonable expenses incurred in carrying out the recall. In providing the Services, the Supplier shall co-operate with and comply with all instructions of AcedrA, including requirements in the Order, and will perform the Services with the best care, skill, and diligence in accordance with best practice in the Supplier's industry, profession or trade. The Supplier shall use personnel who are suitably skilled and experienced to perform tasks assigned to them, and in sufficient numbers to ensure that the Supplier's obligations are fulfilled in accordance with the Order. 6. PACKAGING All Products under the Order shall be securely and adequately packed, and the packaging marked with AcedrA's Order number. All packaging shall be non-chargeable and non-returnable unless otherwise agreed in writing by AcedrA whereupon it may be returned at the Supplier's risk and expense. 7. DELIVERY AND PERFORMANCE Delivery shall be strictly in accordance with the instructions detailed on the Order, including the date of delivery, and shall be at the risk of the Supplier. Delivery shall be made to the delivery address detailed on the Order during the following times unless agreed otherwise by the parties: -Sunday to Thursday - 8.00 a.m. to 4.00 p.m. (Delivery Location Time) in the delivery location in Saudi Arabia. For outside Saudi Arabia (Tunisia, United Arab Emirates, and Egypt) delivery times: -Monday to Friday - 8.00 a.m. to 4.00 p.m. (Delivery Location Time) in the delivery location. Each delivery of the Products should be accompanied by a delivery note that quotes the Order number. Where the Products are being delivered in installments, the delivery note must identify this along with the outstanding balance of Products remaining to be delivered. All temperature-sensitive Products must be clearly labeled to identify them as such and transported within the manufacturer's required storage temperature parameters. If for whatever reason delivery is not affected in accordance with the Order, then AcedrA may, without prejudice to any other right or remedy, wholly or partially terminate the Order without incurring liability to the Supplier. The Supplier shall meet any performance dates for the Services specified in the Order or that AcedrA notifies the Supplier. Title in the Products shall pass to AcedrA on the unloading of the Products at the delivery address detailed on the Order (or for international orders at the import terminal prior to customs clearance). Such passing of title shall not constitute acceptance of the Products. In the event of AcedrA being unable to accept deliveries, for whatever reason, AcedrA shall have the right to suspend, wholly or in part, deliveries under the Order. 8. INSPECTION AND REJECTION AcedrA shall have the right to inspect the Products when delivered and to review the Services. If the Products are not delivered on the delivery date identified in the Order, or if the Products and/or Services do not conform with the Order or do not comply with clause 5 of these conditions, then, without limiting any of its other rights or remedies, and whether it has accepted the Products or Services, AcedrA may: reject the Products or Services (in whole or in part) and return them to the Supplier at the Supplier's own risk and expense. Any Products or Services rejected shall be deemed as not having been delivered or performed; require the Supplier to repair or replace the rejected Products, to provide repeat performance of the Services, or to provide a full refund of the price of the rejected Products or Services; recover from the Supplier any costs incurred by AcedrA in obtaining substitute goods or services from a third party; and claim damages for any other costs, loss, or expenses incurred by AcedrA which are in any way attributable to the Supplier's failure to carry out its obligations. 9. PRICE Prices shall be as stated on the face of the Order and unless agreed otherwise shall be exclusive of Value Added Tax or similar tax and customs duties which if applicable shall be payable by AcedrA in addition to the Price at the rate in force under the applicable law. No alterations will be accepted unless by prior written agreement from AcedrA. Prices shall include costs of packaging, insurance, and carriage of the Products and include every cost and expense of the Supplier directly or indirectly incurred in connection with the performance of the Services. 10. INVOICES AND PAYMENT Invoices quoting the Order number, description, and quantity of Products delivered or Services provided shall be forwarded at the time of dispatch or after the completion of the Services to the relevant address as advised by AcedrA. Failure to detail any of the above information may result in a delay in payment by AcedrA. Unless otherwise stated in the Order, payment will normally be made in the month following the month in which the Products or Services in accordance with the Order, and a correct invoice, are received. 11. INDEMNITY In respect of the Order, the Supplier hereby agrees to indemnify and hold harmless AcedrA against all claims, damages, liabilities, and costs (including but not limited to any direct, indirect, or consequential losses, loss of profit, loss of reputation, and all interest, penalties and legal costs (calculated on a full indemnity basis) and all other reasonable professional costs and expenses) suffered or incurred by AcedrA resulting from: any damage, loss, death, or injury caused by an act, negligence, or omission arising out of or in connection with defects in Products or Deliverables, to the extent that the defects in the Products and Deliverables are attributable to the acts or omissions of the Supplier, its employees, agents or its subcontractors; any defect in or damage to the Products caused by or contributed to by the Supplier; any alleged or actual infringement of any Intellectual Property Rights in existence or pending at the date of the Order relating to the manufacture, supply, or use of the Products, or receipt, use, or supply of the Services and Deliverables; and any breach of Sanctions Laws. This clause shall survive the termination of an Order. 12. ASSIGNMENT The Supplier hereby agrees that no work in pursuance of the Order shall be assigned without the prior written consent of AcedrA. 13. CONFIDENTIALITY All confidential information associated with the Order, including confidential information concerning the business, affairs, customers, clients, or suppliers of the other party, shall be treated as strictly confidential between AcedrA and the Supplier. 14. PARTIAL INVALIDITY AND WAIVER Any provision of the Order subsequently found to be invalid shall not in any way affect the validity or enforceability of the remainder of the Order. Any failure by either party to enforce any provision of the Order shall not be construed as a waiver of that or any other provision. 15. NOTICES Any Notice or other communication entered into shall be in writing and addressed to the Supplier if notices are being given to the Supplier, or to the AcedrA entity named in the Order if notices are being given to AcedrA. 16. INTELLECTUAL PROPERTY All Intellectual Property Rights in Deliverables or arising out of or in connection with the Services (other than Intellectual Property Rights in any materials in the Deliverables that were owned by the Supplier prior to providing the Services ("Background IP") shall be owned by AcedrA unless agreed otherwise between the parties. The Supplier hereby assigns to AcedrA or shall procure the assignment to AcedrA of, all rights, title, and interest in the Deliverables (except to the Background IP) anywhere in the world. The Supplier hereby grants AcedrA a fully paid-up, non-exclusive, royalty-free, irrevocable, and perpetual license to use, modify and publish the Background IP to the extent it is incorporated in the Deliverables so that AcedrA may use the Deliverables in any way it wishes. AcedrA grants the Supplier a fully paid-up, non-exclusive, royalty-free non-transferable license to copy and modify any materials provided by AcedrA to the Supplier for the term of the Order for the purpose of providing the Services to AcedrA. 17. TERMINATION For Convenience- AcedrA shall have the right to terminate the Order in whole or part, at any time before delivery of the Products or completion of the Services, by serving on the Supplier written notice of termination. Upon receipt of such notice of termination, all terminated work shall be discontinued and AcedrA shall pay to the Supplier such sum as is fair and reasonable in respect of any direct loss sustained by the Supplier by reason solely of such termination and the Supplier agrees to accept such sum in full and final satisfaction of all claims arising out of such termination. In the event of termination of the Order, the Supplier shall use its best endeavors to mitigate the loss arising from such termination. In no case shall the amount payable by AcedrA for the terminated Services or Products exceed the price that would have been payable if the Services had been completed or the Products delivered. For Default- AcedrA shall notify the Supplier of any breach or default of these conditions. If the Supplier is unable to remedy such breach or default within a period of 30 days from the notice being given, then AcedrA reserves the right to terminate the Order in whole or part without incurring liability to the Supplier. For Insolvency- In the event that the Supplier becomes insolvent then AcedrA reserves the right to suspend or terminate the Order without incurring liability to the Supplier. Termination of an Order, however arising, shall not affect any of the parties rights and remedies that have accrued as at termination, including the right to claim damages in respect of any breach of these conditions which existed at or before the date of termination. 18. FORCE MAJEURE Neither party shall be in breach nor liable for delay in performing, or failure to perform, any of its obligations under these conditions if such delay or failure results from events, circumstances, or causes beyond its reasonable control. In such circumstances, the affected party shall be entitled to a reasonable extension of the time for performing such obligations. If the period of delay or non-performance continues for 2 weeks, the party not affected may terminate the Order immediately by giving written notice to the affected party. 19. DATA PRIVACY Where AcedrA processes your personal data in relation to the purchase of Products or Services under the Order we will comply with any applicable data protection legislation currently in force, including but not limited to governed by the Personal data protection law (Royal Decree No. (M/19) dated 1443/2/9 AH) , the Main Principles of Personal Information Protection, and the Main Principles and General Rules for Sharing Data issued by the Saudi Data and Artificial Intelligence Authority (SDAIA) and National Data Management Office (NDMO) . and any national implementing laws, regulations, and secondary legislation, as amended or updated from time to time and any successor legislation thereto. 20. ANTI-BRIBERY AND CORRUPTION Both AcedrA and the Supplier shall not, and shall procure that their respective directors and employees shall not, engage in any activity, practice, or conduct which would constitute an offense under any anti-bribery and anti-corruption laws, regulations, and codes in any jurisdiction, including but not limited to the Anti-Money Laundry of Saudi Arabia 20217 the UK Bribery Act 2010 and, where applicable, the US Foreign Corrupt Practices Act 1977 . 21. MODERN SLAVERY Each party shall and shall procure (where relevant) that all persons who are performing services or providing goods in connection with, or which will or may be used in performing or to support the performance of these conditions in any part of the world (collectively, its "Supply Chain") shall at all relevant times (a) comply with the provisions of Anti-Trafficking in Persons Law Royal Decree no. M/40, dated 21/7/1430H ; (b) not engage in any activity, practice, or conduct that would constitute an offense under the Anti-Trafficking and Modern Slavery Statement of AcedrA if such activity, practice, or conduct were carried out in the Kingdom of Saudi Arabia; and (c) take all reasonable steps to ensure that slavery and human trafficking are not taking place in its business or its Supply Chain. 22. SANCTIONS The Supplier and AcedrA acknowledge the existence of Sanctions Laws and shall ensure that they comply with all applicable Sanctions Laws to which either the Supplier or AcedrA is subject, including those of any jurisdiction where either the Supplier or AcedrA are located or incorporated. The Supplier and AcedrA shall not take any action or refrain from taking any action which would, or would in the reasonable opinion of the party subject to Sanctions Laws, cause the such party to breach such Sanctions Laws. The Supplier shall carry out appropriate due diligence with regard to any third party involved in the supply of the Products and Services. The Supplier shall ensure that it has no knowledge or reasonable cause to suspect that any activities relating to the Products or Services will, either directly or indirectly, involve any Sanctioned Person or will otherwise be in breach of Sanctions Laws. In the event of either party becoming a Sanctioned Person, the other party may terminate any Orders with immediate effect and without payment of compensation. 23. APPLICABLE LAW This Agreement and any Order shall be subject to and interpreted in accordance with the Laws of the Kingdom of Saudi Arabia and the Supplier hereby submits to the jurisdiction of the Saudi Courts. AcedrA T&Cs of Sales 1. DEFINITIONS In these terms and conditions (“T&Cs”), the following definitions shall apply: “Clinical Trial Products” means any products ordered from Us by You including without limitation pharmaceutical compounds and drugs, medical equipment, and medical supplies which are ordered by You for use strictly in connection with any clinical trial; “AcedrA Subsidiary” means any person that directly or indirectly is controlled by AcedrA Pharmaceutical Company LLC; “Contract” means any contract between You and Us incorporating these T&Cs for the sale of Products and/or the provision of the Services; “controlled by” means the power to direct or cause the direction of the management or policies of a person whether through the direct or indirect ownership of voting securities, by contract, resolution, regulation, or otherwise; “Field of Use” means the field of use and/or application for which You have engaged Us to perform the Services as stated in the Quotation where provided by Us and agreed by You or as otherwise agreed by Us and You in writing in an order placed by You and accepted by Us; “General Products” means any products ordered from Us by You including without limitation pharmaceutical compounds and drugs, medical equipment and medical supplies, and any ancillary Services required, but excluding the Clinical Trial Products; “Liability” means liability for any and all damages, claims, proceedings, actions, awards, expenses, costs, and any other losses and/or liabilities; "Order" means Your purchase order form, or Your written acceptance of Our Quotation, as the case may be; “Products” means General Products and Clinical Trial Products; “Quotation” means, where provided by Us, the form completed and signed by Us and You, confirming the price for the Products and Services and other variable details specific to your order; “Sanctions Laws” means any law, regulation, or wider measure applicable to either You or Us relating to the adoption, implementation, and enforcement of economic sanctions, export controls, and trade embargos; “Sanctioned Person” means any individual, entity, or body (i) specifically designated under Sanctions Laws, (ii) owned or controlled by any individual, entity, or body specifically designated or listed under Sanctions Laws, or (iii) acting for or on behalf of any individual, entity or body specifically designated or listed under Sanctions Laws; “Services” means without limitation the sourcing, procurement, and/or distribution of medicinal products, comparator drugs, other health products, medical supplies, and equipment, and managed access, clinical trials, pharmaceutical, clinical consultancy and advisory services, and/or work; “We, Us, Our” means AcedrA Pharmaceutical Company LLC or any AcedrA Subsidiary; “You, Your, Yourself” means the person, organization, or other business entity whose order for Products and/or Services is accepted by Us and to whom We subsequently supply the Products and/or Services. 2. BASIS OF CONTRACT AND QUOTATIONS 2.1 These T&Cs shall govern the agreement between You and Us to the exclusion of any other terms or conditions, including the exclusion of any terms or conditions which You may purport to apply under any purchase order, confirmation order, or similar document except that in the event of any conflict between these T&Cs and any signed agreement between You and Us the signed agreement shall take precedence. 2.2 No oral warranties or representations shall bind Us. No variation of these T&Cs shall be binding on Us unless agreed in writing between You and one of Our authorized representatives or contained in the relevant Quotation where provided by Us. Our employees, sub-contractors, and/or agents are not authorized to make any representations or warranties concerning the Products and/or Services unless confirmed by Us in writing. You acknowledge that You do not rely on any representation and/or warranty that has not been made in accordance with these T&Cs. 2.3 Quotations will not form part of the Contract unless accepted by signature by both You and Us within the time period specified on the Quotation ("Quotation Offer Period"). Quotations may be withdrawn by Us at any time during the Quotation Offer Period by oral or written notice. Notwithstanding this, We shall have the right to refuse to accept any orders placed for Products and/or Services under the Quotation. 2.4 All of these T&Cs shall apply to the supply of both Products and Services except where application to one or the other is specified. 3. Orders 3.1 The Contract between You and Us shall come into effect on Our acceptance of Your Order. No Order shall be deemed accepted by Us until confirmed in writing by Our authorized representatives. 3.2 You shall be responsible for the accuracy of an Order and for giving Us any information necessary to perform the Contract. 3.3 If You approve sample Products supplied by Us then You shall have no claim in respect of, nor any right to reject, the Products, provided those Products are of the same description, specification, quality, and fitness for purpose as the sample. 4. Delivery and performance 4.1 We shall deliver the Products to the location set out in the Order or such other location as the parties may agree ("Delivery Location"). We will use Our reasonable commercial endeavors to ensure delivery and/or performance on the dates specified in the Order, but dates for delivery and/or performance are estimates only and are not guaranteed. Time is not of the essence in relation to such dates and late delivery or perfor mance shall not entitle You to cancel the Order. They are also subject to any matter beyond Our reasonable control. 4.2 Delivery shall be deemed to occur: 4.2.1 where Products are delivered by Us to You: at the time when the Products arrive at the Delivery Location; or 4.2.2 where Products are collected by You: on collection from the designated collection address and in any event, no later than 3 Working Days after You have been notified that the Products are available for collection in accordance with clause 4.9. 4.3 Where we require the return of any packaging material, You shall make any such packaging materials availa ble for collection at such times as We shall reasonably request. Returns of packaging materials shall be at Our expense. 4.4 If Products are to be delivered in installments , each delivery shall constitute a separate and distinct contract. Failure by Us to deliver, or a claim by You regarding, any installment under a separate and distinct contract shall not entitle You to repudiate and/or terminate the Contract as a whole or any other separate and distinct contract or Order. 4.5 Where Services are to be performed in stages, each stage shall constitute a separate and distinct contract. Failure by Us to deliver or any claim by You in respect of, any stage under a separate and distinct contract shall not entitle You to repudiate and/or terminate the Contract as a whole or any other separate and distinct contract or Order. 4.6 We shall not be required to fulfill Orders for Products and/or Services in the sequence in which they are placed. 4.7 You shall procure during normal working hours that We have free rights of access to the Delivery Location or the relevant location to perform the Services. You shall be responsible at Your own cost for all arrangements to unload the Products when delivered to You. Unless otherwise agreed in writing, delivery of Products and performance of Services will be made between 0800 hours and 1700 hours, Sunday to Thursday, excluding public holidays in Saudi Arabia and the country of the Delivery Location (“Working Days”). 4.8 If You fail or refuse to t ake delivery of any Products and/or to allow performance of the Services then We shall be entitled to withhold delivery and/or performance of those Products and/or Services and to treat the Contract for that particular Order as repudiated by You. If any delay to take delivery of any Products is caused by You, We may store the Products for at least 7 Working Days in accordance with clause 4.9, and charge You for all related costs and expenses (including insurance). 4.9 If We agree that the Products are to be collected from Us by You then You shall collect the Products within 3 Working Days of being notified that the Products are ready for collection. If the Products are not collected by You within this tim e We may store the Products at Your expense and risk until collection. 4.10 If after 7 Working Days, you do not rectify the failure or refusal to take delivery of Products or to allow performance of the Services under clause 4.9, or You do not collect the Products from Us within the time period specified in clause 4.9, We may in Our discretion sell or otherwise dispose of part or all of the Products and will no longer make the Services available to you. 4.11 Where the quantity of Products delivered is not in accordance with the Order, You must notify Us within 3 working days of delivery or within 1 day of delivery in relation to cell therapy or gene therapy Products. We will remedy any shortfall in delivery where We consider an error in the order has occurred solely by Us. 4.12 If We accept that any Services we have supplied have not been supplied in accordance with the Contract We will perform such Services again so that they are in accordance with the Contract. 5. Damaged and Defective Products 5.1 Any Products which are alleged to be defective or damaged must be notified to Us within 5 Working Days of delivery or collection, or within 1 day of delivery or collection in relation to cell therapy or gene therapy Products, with a written report of the alleged defect or damage, and where reasonable and if requested by Us be returned to Us within 10 Working Days of the date of delivery or collection in their original boxes and packaging for inspection. We will alert the Product manufacturer as quickly as reasonably possible and: 5.1.1. if the Products are confirmed as being defective then a credit for the price of the defective Products or replacement will only be issued by Us as authorized by the manufacturer concerned, and whichever option is provided is at the discretion of the manufacturer and/or Us; and 5.1.2. if the Products are confirmed as being damaged then either a refund or credit will be offered to You at Our discretion. 5.2 We will not accept Product returns except solely where agreed by Us in accordance with these T&Cs or in relation to a Product recall. 5.3 If, after the time periods referred to in clause 5.1 have passed and You have not raised any allegations of defective or damaged Products, You are deemed to have accepted the Products. 6. Postponement and Cancellatio n 6.1 We may comply with reasonable requests by You for postponement of delivery and/or performance but shall be under no obligation to do so. Where delivery and/or performance is postponed at Your request and We have agreed to that postponement, then We may require that You pay all Our costs and expenses incurred as a result including, but not limited to, reasonable charges for storage, transportation, and insurance. In addition, You shall be obliged to pay for the Products and/or Services in accordance with clause 7 as if delivery and/or performance had not been postponed. 6.2 If You wish to cancel an Order which has been accepted by Us, you must notify us immediately. Except where cancellation occurs in accordance with clause 8.1, at Our discretion, we may agree to the cancellation of the Order and termination of the relevant Contract. Our agreement to terminate the Contract for that Order will only be effective upon one of Our authorized representatives agreeing to it in writing. Notwithstanding our acceptance of a cancellation, We may require in Our discretion that You indemnify Us in full against all loss (including loss of profit), costs (including the cost of all labor and materials used), damages, charges, and expenses incurred by Us as a result of cancellation. 6.3 If you purport to cancel an Order without our consent an d/or refuse to accept delivery of ordered Products and/or the performance of any ordered Services You will: 6.3.1 have no further recourse against Us under the Contract; and 6.3.2 indemnify and keep Us indemnified against any and all lost profits, costs (including increased administration costs and legal costs on a full indemnity basis), expenses, damages, and any other loss and/or Liability suffered by Us as a result. 7. Price, Payment, and Credit Limit 7.1 The price of the Products and/or the Services shall be as specified in the Quotation or where no Quotation is signed by Us and You, as otherwise specified in writing by Our authorized representatives and confirmed in a written order. Except as otherwise stated, prices are exclusive of any transport, packaging, and/or insurance costs and are exclusive of any applicable taxes and duties for which You shall additionally be liable. 7.2 Where any taxable supply for Value Added Tax or similar tax purposes is made under the Contract by Us to You, You shall, on receipt of an invoice from Us, pay to Us such additional amounts in respect of such Value Added Tax or similar tax as are chargeable on the supply of the Services or Products at the same time as payment is due for the supply of the Services or Products. 7.3 We may increase Our prices where an increase in costs, expenses, and/or materials is suffered by Us (including, without limitation, any factor outside of Our control such as any foreign exchange fluctuation, currency regulation, and alteration of duties). You will be informed in advance and in writing by Us of any price increases for the Products and/or the Services as soon as practicable after we become aware of any changes. You may cancel without Liability any Contract in relation to which the price is to be increased, provided that the notice of cancellation is received by Us before the change becomes effective. 7.4 If Y ou do not cancel the Contract for the provision of the Products and/or Services before the price increase becomes effective then the price increase shall take effect for the Products and/or Services ordered by You. 7.5 Unless otherwise agreed in writing by Us or specified in the Quotation: 7.5.1 Our terms of payment are 30 days from the date of invoice; 7.5. 2 time for payment shall be of the essence; 7.5.3 all invoices issued on a pro-forma basis are due for immediate payment; and 7.5.4 payment of a n invoice shall be in full and in cleared funds to a bank account nominated in writing by Us. 7.6 If You fail to make any payment in full on the due date then, without prejudice to any other right or remedy available, We may charge You any reasonable additional administration costs and/or interest (both before and after judgment) on the amount unpaid at the rate of 4% per annum above the base rate from time to time of Our bank. 7.7 We may invoice each delivery of Products and/or stage of the Services separately. We will render an invoice to You at any time and/or at any stage during the performance of the Contract. 7.8 You shall pay all sums due to Us without any set-off, deduction, counterclaim, and/or any other withholding. Payment shall not be deemed to be made until We have received either cash or cleared funds in respect of the full amount outstanding. 7.9 If payment in full is not made to Us when due then We may withhold or suspend future or current deliveries of the Products and/or performance of the Services and delivery and/or performance under any other agreement with You and/or cancel the Contract. 7.10 If any Services are canceled, the Contract is terminated, or delivery and/or performance is suspended before the completion of the Services, We are entitled to be paid on a quantum meruit basis for that part of the Services performed. We may invoice You accordingly and such monies shall be due for payment in accordance with clause 7.5. 7.11 We may set a reasonable credit limit for You. We may refuse to accept orders for Products and/or Services and/or suspend or withhold delivery of Products and/or Services if such Products and/or Services would result in You exceeding or you have exceeded Your credit limit. 8. Specification, Intellectual Property Rights, and Confidentiality 8.1 Specifications supplied by Us to You shall only be approximate unless stated in the Quotation or otherwise agreed in writing. If there is an error in the specification made by Us in the Quotation or as otherwise agreed in writing by Us, where that error is material and it has been relied upon by You, You may cancel that part of the Contract only which is affected by the error without Liability due to the cancellation in respect of that part canceled. 8.2 The quantity, quality, description, and/or specification for the Products and/or the Services shall be that set out in Your Order. You are responsible for checking the Order and satisfying Yourself that any specification given is accurate and adequate for the Products and/or Services. 8.3 We shall have no liability for errors in any specification or details supplied by You. We will use all reasonable endeavors to provide final products to the same specification as proofs or samples, however, no guarantee is expressed or implied that the entire consignment of Products will have the same specification as the sample. 8.4 We warrant that, where Products are supplied by description and not sample, on delivery, the Products will comply with their description in the Order in all material respects. We warrant that the Services will be provided using reasonable care and skill. 8.5 You shall not make any modification to the Products or their packaging, nor alter, remove, or tamper with any trademarks used on or in relation to the Products and/or Services. All intellectual property rights (including without limitation all patents, copyright, design rights (whether registered or unregistered), trademarks (whether registered or unregistered) skill and/or know-how, and other similar rights, whether existing now and/or in the future, wherever existing in the world together with the right to apply for protection of the same): 8.5.1 in the Products and/or their packaging shall be owned by Us or the relevant manufacturer (as appropriate) absolutely; 8.5.2 arising from the Services shall be owned by Us absolutely (excluding materials provided by You to Us in order to perform the Services). 8.6 You will at Our cost and request, do all acts and/or things and execute all documents and/or deeds to give effect to clause 8.5 above and/or to assist Us in the application, registration, renewal, and/or protection of such intellectual property rights. 8.7 We reserve absolutely all rights to be identified as the authors of any works arising and/or generated from the Services in accordance Saudi Authority for Intellectual Property . We may utilize for the benefit of Our other customers any skill and/or know-how developed and/or acquired in the performance of the Services. 8.8 We grant to You a non-exclusive royalty-free license to use within the Field of Use all intellectual property rights owned by Us which arise solely from the Services except that We shall be entitled to use such intellectual property rights inside and outside of the Field of Use for ourselves and for con ducting other research and/or projects for Our other customers. All rights and licenses not specifically and expressly granted to and conferred upon You by the Contract are for all purposes reserved to Us. 8.9 We may terminate the license granted under clause 8.8 at any time with immediate effect upon notice if any of the events in clause 10.2 occur in relation to You and/or if You use, attempt to use, and/or We reasonably suspect that you intend to use the intellectual property rights (specified in clause 8.5) arising from the Services otherwise than in accordance with the Contract. 8.10 You grant to Us a fully paid-up, non-exclusive, royalty-free license to copy and modify any materials provided by You to Us for the term of the Contract for the purpose of providing the Services. 8.11 Each party undertakes that it shall not at any time during the Contract, and for a period of five years after termination or expiry of the Contract, disclose to any person any confidential information concerning the business, affairs, customers, clients or suppliers of the other party, except as permitted by clause 8.12. 8.12 Each party may disclose the other party's confidential information: 8.12.1 to its employees, officers, representatives, contractors or subcontracts, or advisers who need to know such information for the purposes of exercising the party's rights or carrying out its obligations under or in connection with the Contract. Each party shall ensure that its employees, officers, representatives, or advisers to whom it discloses the other party's confidential information comply with this Clause 8; and 8.12.2 as may be required by law, a court of competent jurisdiction, or any governmental or regulatory authority. 8.13 No party shall use any other party's confidential information for any purpose other than to exercise its rights and perform its obligations under or in connection with the Contract. 9. Property and Risk 9.1 Risk in the General Products under an Order shall pass to You at the time of delivery as identified in clause 4.2. 9.2 We shall retain the title of the General Products under an Order until We have received payment in full in cash or cleared funds of all sums due and/or owing in relation to those General Products. 9.3 Until We have received full payment for General Products supplied to You, You shall store the General Products separately from any products or goods belonging to You or any third party and the General Products must be clearly identified as being Our property. You agree that Our employees and/or agents shall be entitled to enter Your premises to check compliance with this clause, and You agree to provide them with access. You shall properly store and protect the General Products and keep the General Products insured for the price at which the General Products were sold to You against all insurable risks and shall hold any proceeds of such policy of insurance relating to the General Products on trust for Us and account to Us for any proceeds of such policy of insurance relating to the General Products upon receipt of the same. Any monies received from You by Us in accordance with this clause shall not discharge Your liability to pay the price for the General Products plus interest accrued in accordance with clause 7.6 but shall be set off against such liability. 9.4 In the event that there is no payment due for the General Products provided by Us to You, the title shall pass to You at the time of delivery as defined in clause 4.2. 9.5 Title to the Clinical Trial Products and liability for risk of loss or damage shall pass from Us to You immediately after We have purchased and ourselves acquired title to the relevant Clinical Trial Products. You shall be responsible for arranging insurance in respect of the Clinical Trial Products immediately after We have purchased the relevant Clinical Trial Products. We shall only be liable for any damage caused to the Clinical Trial Products, on a contractual or non-contractual basis, to the extent that such damage is caused by Our wilful misconduct or recklessness. 10. Termination and Default 10.1 Without affecting any other right or remedy available to it, either party may terminate a Contract by giving the other party not less than 12 months' written notice. 10.2 If You:- 10.2.1 fail to make payment to Us when due; 10.2.2 breach the terms of the Contract and, if capable of remedy, have not remedied the breach within 10 Working Days of receiving notice requiring it to be remedied; 10.2.3 persistently breach any one or more terms of the Contract; 10.2.4 pledge or charge any Products which remain Our property, or cease or threaten to cease to carry on business, or propose to compound with Your creditors, apply for an interim order under Section 252 Insolvency Act 1986 or have a Bankruptcy Petition presented against You, enter into voluntary or compulsory liquidation, have a receiver, administrator or administrative receiver appointed over all or any of Your assets, or take or suffer any similar action in any jurisdiction; 10.2.5 appear from Your credit rating to be financially unable to meet Your obligations under the contract; and/or 10.2.6 appear reasonably to Us to be about to suffer any of the events described in 10.2.4 and 10.2.5; then We shall have the right, without prejudice to any other remedies, to exercise any or all of the rights set out in clause 10.3. 10.3 If any of the events in clause 10.2 occur in relation to You then:- 10.3.1 We may enter, without prior notice, and You shall give us access to, any of Your premises (or premises of third parties, of which You shall procure that We are given access to) where Products owned by Us may be and repossess and dispose of or sell any Products found which are owned by Us so as to discharge any sums due to Us under this Contract or any other agreement with You; 10.3.2 We may require You not to re-sell or part with the possession of any Products owned by Us until You have paid in full all sums due to Us under the Contract or any other agreement; 10.3.3 We may withhold delivery of any undelivered Products and/or performance of any Services and stop any Products in transit and/or cease any Services in progress; 10.3.4 We may cancel, terminate and/or suspend without Liability to You any agreement with You; and/or 10.3.5 All monies owed by You to Us shall become due and payable immediately. 10.4 Additionally, if any of the events in clauses 10.2.4 – 10.2.6 occurs in relation to You, We shall have a lien over all property or goods belonging to You in Our possession in respect of all sums due from You to Us, and upon the termination of the Contract if monies due to Us from You have not been paid within 7 Working Days of termination We may sell any property or goods over which We have a lien (and You agree that We may give good title for such property and/or goods) and shall apply the proceeds of sale firstly in discharging any costs or expenses of sale, secondly in repaying any interest or expenses owed by You to Us, thirdly in payment of any principal sums owed to Us and fourthly We shall account to You for the remainder (if any). 11. Limitations On Liability 11.1 We shall have no Liability: 11.1.1 for any loss arising from the use of the Product by an end user unless such Liability can be demonstrated to have arisen as a direct result of our wilful misconduct or recklessness in handling the supply of the Product; 11.1.2 for any defect in the Products caused or contributed to as a result of the Products being used for display or demonstration purposes or being handled by You or Your customers; 11.1.3 for defective Products and/or Services where (i) the defect has been caused or contributed to by You to the extent so contributed; (ii) You continue to use the Products or Services after giving notice of defect under clause 5; (iii) the defect arises because You failed to follow Our oral or written instructions as to the storage, installation, commissioning, use or maintenance of the Products; (iv) the defect arises as a result of Our following instructions from You to alter or amend the Products; (v) You alter or repair the Products without Our consent; or (vi) the defect arises as a result of wilful damage or negligence by You; 11.1.4 to You for breach of warranty where the Products differ from their description as a result of changes made to ensure they comply with applicable statutory or regulatory standards; 11.1.5 to You if the price for the Products and/or the Services has not been paid in full by the due date for payment; 11.1.6 to You for defective or damaged Products and/or Services and incorrect quantity of Products delivered unless the event is notified to Us within the appropriate time limit set out in the Contract; 11.1.7 to You for Products not despatched or Products lost in transit unless the event is notified to Us within 3 Working Days of such event occurring; 11.1.8 for damage, loss, liability, claims, costs, or expenses caused or contributed to by the continued use of defective Products and/or Services after a defect has become apparent or suspected or should reasonably have become apparent to You; 11.1.9 to You to the extent that You are covered by any insurance policy and You shall ensure that Your insurers waive any and all rights of subrogation they have against Us; 11.1.10 for any consequential losses, including but not limited to: loss of profits and/or damage to goodwill; economic and/or other similar losses; special damages and indirect losses; and/or business interruption, loss of business, contracts, opportunity, and/or production. 11.2 You shall: 11.2.1 give Us an opportunity to remedy any matter for which We are liable before You incur any costs and/or expenses in remedying the matter Yourself; 11.2.2 produce to Us written evidence of any claims you allege that We are liable together with written details of how the loss was caused and the steps taken by You to mitigate the loss; 11 .2.3 be under a duty to mitigate any loss, damage, costs, or expenses that You may suffer (including by maintaining an adequate stock of Products). 11.3 Our total Liability to You shall not exceed: 11.3.1 in respect of any claims relating to Clinical Trials Products, an amount equal to 10 (ten) percent of the value of the Clinical Trials Products to which the relevant claim relates; or 11.3.2 in respect of any other claims, SAR 1,000,000 (1 million Saudi Riyals). 11.4 Each of the limitations and/or exclusions on liability in the Contract shall be deemed to be applicable for each of: 11.4.1 Liability for breach of contract; 11.4.2 Liability in tort (including negligence); 11.4.3 Liability for breach of statutory duty; 11.4.4 Liability for breach of Saudi Trade Law, except clause 11.3 above which shall apply once only in respect of all the said types of Liability; and 11.4.5 All warranties, terms, conditions, and duties implied by law relating to fitness, quality, or adequacy are excluded to the fullest extent permitted by law. 11.5 Nothing in the Contract shall exclude or limit Our Liability for death or personal injury due to Our negligence or any Liability which is due to Our fraud or fraudulent misrepresentation or any other liability which it is not permitted to exclude or limit as a matter of law. 11.6 You will indemnify and keep indemnified Us against any and a ll losses, proceedings, lost profits, damages, awards, expenses, costs (including increased administration costs and legal costs on a full indemnity basis), claims, actions and any other losses and/or liabilities suffered by Us and arising directly or indirectly from or due to: 11.6.1 any loss arising from the use of the Product by an end user unless such Liability can be demonstrated to have arisen as a direct result of Our actions in handling the supply of the Product; 11.6.2 an y breach of contract, any tortious act and/or omission, and/or any breach of statutory duty by You; 11.6.3 any breach by You of Sanctions Laws; and/or 11.6.4 Our use of specifications, details, and/or stipulations supplied by You. 12. Data Privacy 12.1 Where We process your personal data in relation to the purchase of Products or Services under the Contract We will comply with any applicable data protection legislation currently in force, including but not limited to governed by the Personal data protection law (Royal Decree No. (M/19) dated 1443/2/9 AH) , the Main Principles of Personal Information Protection, and the Main Principles and General Rules for Sharing Data issued by the Saudi Data and Artificial Intelligence Authority (SDAIA) and National Data Management Office (NDMO) . any national implementing laws, regulations, and secondary legislation, as amended or updated from time to time any successor legislation thereto. 13. Anti-Bribery and Corruption 13.1 Both We and You shall not, and shall procure that Our and Your respective directors, employees, agents, representatives, contractors, or sub-contractors shall not, engage in any activity, practice, or conduct which would constitute an offense under any anti-bribery and anti-corruption laws, regulations and codes in any jurisdiction, including but not limited to the Anti-Money Laundry of Saudi Arabia 20217 and the UK Bribery Act 2010 and, where applicable, the US Foreign Corrupt Practices Act 1977 . 14. Modern Slavery 14.1 Both parties shall and shall procure that its directors and employees shall at all relevant times (a) comply (a) comply with the provisions of Anti-Trafficking in Persons Law Royal Decree no. M/40, dated 21/7/1430H ; (b) not engage in any activity, practice, or conduct that would constitute an offense under the Anti-Trafficking and Modern Slavery Statement of AcedrA if such activity, practice, or conduct were carried out in the Kingdom of Saudi Arabia; and (c) take all reasonable steps to ensure that slavery and human trafficking are not taking place in its business or its Supply Chain. 15. Sanc tions 15.1 Both We and You acknowledge the existence of Sanctions Laws. We shall ensure that We comply with all applicable Sanctions Laws to which We are subject, including those of any jurisdiction where We are located or incorporated. You shall ensure that You comply with all applicable Sanctions Laws to which You are subject, including those of any jurisdiction where You are located or incorporated. 15.2 Both We and You shall not take any action or refrain from taking any action which would, or would in the reasonable opinion of the party subject to Sanctions Laws, cause the such party to breach such Sanctions Laws. 15.3 You shall carry out appropriate due diligence with regard to any third party to whom the Products or Services are re-sold, re-supplied, re-exported, or re-transferred. You shall ensure that You have no knowledge or reasonable cause to suspect that any activities related to the Products or Services will, either directly or indirectly, involve any Sanctioned Person or will otherwise be in breach of Sanctions Laws. 15.4 In the event of Us or You becoming a Sanctioned Person, the other party may terminate any Contracts with immediate effect and without payment of compensation. 16. General 16.1 No waiver by Us of any breach of the Contract shall be considered as a waiver of any subsequent breach of the same provision or any other provision. If any provision of the Contract is held by any competent authority to be invalid or unenforceable in whole or in part the validity of the other provisions of the Contract and the remainder of the affected provision shall be unaffected and shall remain in full force and effect. 16.2 Either party shall have no Liability to the other for any delay in performance of the Contract (other than in relation to payment) where such delay is due to events outside the affected party's reasonable control including without limitation to acts of Allah, war, flood, fire, labor disputes, subcontractor delays, strikes, lock-outs, riots, civil commotion, malicious damage, explosion, governmental actions, and any other similar events. If a party is affected by such events then the time for performance shall be extended for a period equal to the period that such events delayed performance. 16.3 You shall not assign Your interest in the Contract (or any part) without Our written consent. We may assign, transfer, or sub-contract all or any part of our obligations and/or interest in the Contract to any third party without notice. 16.4 All third-party rights are excluded and no third party shall have any right to enforce the Contract. Any right of a third party to enforce the Contract may be varied and/or extinguished by agreement between the parties to the Contract without the consent of the such third party. 16.5 The Contract is governed by and interpreted in accordance with the Kingdom of Saudi Arabia law and the parties agree to submit to the exclusive jurisdiction of the Saudi Courts. AcedrA T&Cs of Purchases Consumer Information Obligations Our main activity within AcedrA relates to the supply of packaged goods/goods that are packaged to the final user of the packaging, someone who will discard that packaging. This could be postal packaging, such as if we sell products to a distributor who removes our packaging and repackages the products, or it could be selling a packaging product to the final end user. To this end, we are required under the Consumer information obligations to give our customers information about: return, collection, and recovery systems they can use their role in reusing, recovering, and recycling packaging and packaging waste what do recovery and recycling symbols on the packaging mean how to get copies of waste strategy guidance In order to achieve this AcedrA has provided links below to the relevant government websites that provide this information. the Saudi Investment Recycling Company (SIRC) AcedrA Tax Strategy BACKGROUND AcedrA is a trusted Regional and Local Leader in the highly regulated pharmaceutical industry dedicated to enabling quicker and broader access to critical medicines around the world for patients with unmet needs. Our mission is to deliver the right medicine to the right patient at the right time. AcedrA provides innovative pre and post-launch niche services to pharmaceutical and Biotechnology companies to help them accelerate development and access to their medicines and is a ’ go-to place for healthcare professionals to gain access to these critical medicines in licensed and unlicensed markets. Supplying customers in over 8 countries and shipping over 3 million units annually our business activities incur a substantial amount and variety of taxes, including corporate income tax, business rates, stamp taxes, and in the Kingdon of Saudi Arabia, employer’s national insurance. In addition, we collect and pay employment taxes and indirect taxes such as VAT. AcedrA’s core values, outlined in “Our DNA”, encourage honesty and transparency, and we pride ourselves on our integrity and openness and empower our staff to challenge management if these principles are not adhered to. In accordance with the Saudi Finance Laws for Companies , this strategy has been published online and applies to AcedrA and all its subsidiaries and applies from the date of publication until it is superseded. OUR APPROACH TO RISK MANAGEMENT AND GOVERNANCE AcedrA identifies and manages risks and opportunities, including tax risk, that may affect the achievement of its strategic objectives and business plans, its shareholder value, and its reputation, through its risk management process. The Board has responsibility for establishing and maintaining the internal control systems which are monitored to ensure compliance with laws and regulations. The Chief Financial Officer provides updates to the Board on key risks and controls within the company. Tax risk arises due to the complexity of tax legislation and potential differences in interpretation, and in relation to AcedrA’s business operating model. AcedrA has established policies and procedures to ensure the integrity of its tax filings and other tax compliance obligations in the Kingdom of Saudi Arabia and worldwide, and our processes are subject to the same level of internal controls, review, and external audit as the rest of the business. Tax risk is viewed no differently than any other business risk encountered. For routine and established tax compliance procedures, we have a very low tolerance for risk and aim for a high standard of accuracy and compliance with reporting procedures and deadlines. AcedrA has appropriately qualified finance resources who receive the necessary guidance and training to keep up to date with new tax legislation and are supported to seek additional professional tax advice where appropriate. The finance resource maintains regular lines of communication with the commercial and functional teams across the business to ensure the tax effects of business developments are identified and understood. OUR ATTITUDE TO TAX PLANNING We have a responsibility to our shareholders to ensure our operations and financial activities are conducted in a tax-efficient manner. We aim to structure our operations and finances in a tax-efficient manner which may include tax planning. This tax planning is seeking to maximize shareholders' value by utilizing available tax reliefs, incentives, and exemptions where appropriate and ensuring that any arrangements are in the spirit of and comply with the tax legislation in question. Professional advice is sought on a transactional basis, with the depth of that advice driven by our assessment of the risk presented and the level of complexity involved. LEVEL OF TAX RISK WE ARE PREPARED TO ACCEPT AcedrA’s approach to tax planning is to ensure compliance with tax laws and regulations, both in the Kingdom of Saudi Arabia and worldwide, and to ensure that we identify and mitigate tax risks. Tax risk is assessed for each significant transaction. We have no defined limit of the risk we are prepared to accept, we will assess, manage and mitigate the tax risk to an acceptable level on a case-by-case basis. We maintain relationships with reputable external tax advisors that allow us to seek expert advice on specialist areas of tax, and in situations where the tax law is unclear or where internal expertise is insufficient. OUR APPROACH TO DEALING WITH TAX AUTHORITIES AcedrA seeks to ensure its engagement with the Saudi Zakat, Tax and Customs Authority (and other tax authorities in other jurisdictions) is professional, open and honest, and undertaken in the spirit of cooperation. Our aim is to work collaboratively and proactively with tax authorities to resolve matters arising which may include areas such as where legislation or guidance is unclear and there is a significant tax impact. We aim to respond to requests for information in a timely manner and we submit all returns on time. Where appropriate the company seeks advance clearance from tax authorities on the proposed tax treatment of transactions. Reviewed and Updated on 20th of March 2023 AcedrA Board of Directors AcedrA CEO Department AcedrA Compliance Department AcedrA Finance Department AcedrA Operations Department Acedra Commercial Department Hotline: (Toll-Free) 8001240411 legal.affairs@acedrarx.com

Acedr UN F ROM Cèdre Le nom d'AcedrA vient du nom d'un arbre majestueux "Cèdre", très célèbre au Moyen-Orient et dans la région méditerranéenne. Le grand cèdre sera à jamais profondément enraciné dans les histoires anciennes du monde. De son bois solide et polyvalent à son feuillage persistant parfumé et médicinal, le cèdre a soutenu de nombreux peuples différents avec ses innombrables utilisations pendant des millénaires. Le cèdre est traditionnellement connu pour traiter les maladies difficiles. Ainsi, conçu AcedrA! Notre ADN ! Cliquez ici pour découvrir De l'Arabie Saoudite _cc781905-5cde-3194 au monde entier Depuis sa fondation en 2017, AcedrA a rejoint les efforts du royaume via "Vision 2030" pour renforcer le secteur économique non pétrolier et transformer l'Arabie saoudite en une icône mondiale en termes de recherche scientifique et de développement. L'un des trois principaux piliers de la vision 2030, la création d'une "société dynamique" où permettre une vie pleine et saine grâce à l'amélioration des services de santé et de la qualité de vie dans les villes saoudiennes sont les objectifs stratégiques. Cliquez ici pour en savoir plus sur Vision 2030 Représenter le conseil des actionnaires Conseil d'administration Lire la suite Des experts avisés et dévoués Équipe de direction Lire la suite Construit sur les meilleures pratiques de gouvernance Gouvernance Lire la suite Fait partie de notre politique ESG Responsabilité sociale des entreprises Lire la suite Home Our DNA

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Section titre Petit titre Preparing and submitting regulatory submissions: Preparing and submitting documents and applications to obtain regulatory approvals and clearances, such as licenses, permits, and certifications. Petit titre Supporting product registration: Assisting in registering products and services in various countries and jurisdictions, including obtaining the necessary permits and certifications. Petit titre Monitoring and reporting on regulatory changes: Keeping abreast of changes in regulations and ensuring that products and services remain in compliance. Petit titre Facilitating inspections and audits: Preparing for and assisting with regulatory inspections and audits, and responding to regulatory questions and inquiries. Evaluate Evaluating regulatory requirements: Identifying and assessing the regulations and laws that apply to a product or service Our Expertise will unlock your Access MENA region expert When it comes to regulatory affairs in the Middle East and North Africa region, it can be a complex and challenging process. But when regulatory compliance is met and standards are upheld, businesses across the region have access to untapped potential. Our team of regulatory affairs experts helps our clients navigate the intricate regulatory frameworks of this dynamic region to ensure that their products and services meet regulatory requirements. With a deep understanding of local regulatory details, our experienced regulatory professionals provide comprehensive regulatory and compliance services that help businesses reduce risk and maximize their potential in the Middle East and North Africa region. Contact Us Our Pharmacovigilance Activities DSUR Development Safety Update Report QPPV Qualified Person for Pharmacovigilance ICSR Individual Case Safety Report LSR Local Safety Responsible PSMF Pharmacovigilance System Master File PSUR Periodic Safety Update Report PBRER Periodic Benefit-Risk Evaluation Report SUSAR Suspected Unexpected Serious Adverse Event RMP Risk Management Plan PASS Post Authorization Safety Study Ask our experts if you would like to understand the regulatory pathway. Just match the type of your product with the right service that would like to get. Wide Spectrum of Health Products New Drug Request Now Complete Regulatory Affairs Management Marketing Authorizations Request Now Contact Us Section titre Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. To play, press and hold the enter key. To stop, release the enter key. Si vous avez des commentaires sur la gouvernance d'AcedrA, laissez-nous un message et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Regional Presence Medical Support

Gouvernance La gouvernance au sein d'AcedrA est d'une importance primordiale. Il est essentiel de maintenir la responsabilité et de protéger les parties prenantes, ainsi que de positionner l'organisation pour le succès futur . Le respect des meilleures pratiques de gouvernance garantit que le conseil d'administration, le conseil de conformité et l'équipe de direction sont responsables des décisions et des actions prises par l'entreprise. Une bonne gouvernance crée un succès commercial à long terme car elle gère les risques et favorise une meilleure prise de décision dans l'ensemble de l'entreprise. L'organigramme Un conseil d'administration et un conseil de conformité en matière de gouvernance devraient être responsables de l'établissement des politiques, de la planification de la relève et de la protection des parties prenantes contre les problèmes ou responsabilités potentiels. Parallèlement à ces responsabilités, les équipes de direction doivent s'assurer que les mesures de gouvernance sont suivies afin d'utiliser efficacement les ressources et de gérer correctement les risques. Avec la gouvernance en place, ces mesures peuvent créer de la transparence et de l'intégrité, favorisant ainsi des relations crédibles avec les parties prenantes externes. Notre conseil consultatif scientifique rassemble des experts de tous les domaines de la science et de la durabilité, nous donnant leur avis professionnel sur l'efficacité de nos projets et initiatives. Cette contribution inestimable nous permet de continuer à proposer des solutions innovantes qui ont des impacts significatifs sur l'écosystème de la santé dans la région MENA. Avec une combinaison de gouvernance et d'un conseil consultatif scientifique, nous sommes en mesure de garder une longueur d'avance sur les défis environnementaux émergents tout en veillant à ce que nos efforts soient fondés sur des pratiques fondées sur des données probantes. Organes de gouvernance d'AcedrA Conseil d'administration Les CA d'AcedrA assurent le leadership et la supervision afin que nous puissions atteindre nos objectifs et réaliser notre mission. Conseil de conformité Conseil quasi-indépendant ayant pour mission de s'assurer de la pleine conformité de l'organisation. Conseil consultatif scientifique Conseil totalement indépendant ayant pour mission de concevoir le parcours scientifque d'AcedrA. Si vous avez des commentaires sur la gouvernance d'AcedrA, laissez-nous un message et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Our DNA Corporate Social Responsibility

Acedra is a business development powerhouse, providing services that help companies stay competitive and reach their goals faster. Our team of highly qualified professionals is equipped to provide customized guidance and tailor-made strategies for businesses in all stages of growth. Page Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Small Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Small Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Small Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Therapeutic Areas AcedrA Institute

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Section titre Chaque site Web a une histoire et vos visiteurs veulent entendre la vôtre. Cet espace est une excellente occasion de donner un aperçu complet de qui vous êtes, de ce que fait votre équipe et de ce que votre site a à offrir. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez que les visiteurs du site connaissent. Si vous êtes une entreprise, parlez de vos débuts et partagez votre parcours professionnel. Expliquez vos valeurs fondamentales, votre engagement envers les clients et comment vous vous démarquez de la foule. Ajoutez une photo, une galerie ou une vidéo pour encore plus d'engagement. Newsroom Auditors & Advisors

Job Applicant Data Privacy Notice March , 2023 AcedrA Pharmaceutical Company LLC having its registered office at Platinum Centre, Riyadh, Saudi Arabia (“AcedrA”) is responsible for the processing of your personal information as it decides why and how it is processed, thereby acting as the “Data Controller”. It may exercise this responsibility alone or jointly with other company(-ies) affiliated with AcedrA, acting as “co-controller(s)”. In this Privacy Notice, “we” or “us” refers to AcedrA and its Subsidiaries and/or Affiliates. For the purpose of the scope of this data privacy notice (“Notice”), job prospects or candidates mean individuals who apply to an open position with us, who are contacted for or express interest in employment with us, or who attend a recruitment event or undergo an interview or assessment with us. This includes prospective employees, interns, and contractors (who will be further referred to in this Notice as “you”). We invite you to carefully read this Notice, which sets out in which context we are processing information that relates directly or indirectly to you as an individual (“personal information”) and explains your rights with respect to the processing of your personal information. We consider privacy a very important matter. We are committed to ensuring that any personal information we receive is processed and protected in accordance with applicable data protection laws and AcedrA policies and standards. The purpose of this Notice is to clarify the way we are processing personal information. In this context, we are committed to keeping you fully informed about our activities involving the processing of your personal information pertaining to talent management, scouting, assessment and acquisition activities, and application, in general, for positions with us. We have separate privacy notices in relation to processing the personal information of our employees, business partners, patients, and users of our websites, and you should refer to those where appropriate. Should you have any further questions in relation to the processing of your personal information, you are invited to write an email to us at legal.affairs@acedrarx.com 1. What personal information do we process about you? In the context of the above described, we will only process information that is relevant to you as a job prospect or a candidate, which in some cases might require key strategic validations for skills and professional standing. We mainly collect personal information directly from you when you apply for a job in our application management system or when you participate in an interview or assessment. In such cases, we will act as a Data Controller of your personal information. We can also obtain information from professional social networks, such as LinkedIn or other job boards, and from other publicly accessible sources (only information relevant to your professional life) for the purposes of actively approaching you with job opportunities. Should we not have already received your agreement to hold your data, on our initial contact with you, we will ask for your consent to hold your data. We may also receive personal information when you apply through third parties like recruitment agencies or consultants. In such cases, the third party may also act as a Data Controller of your personal information. To exercise your data protection rights for the processing activities carried out by such third parties; you may need to contact the third party through which you have applied for a position with us. We may also receive your information (email address) when an employee has referred you for a position with us under the employee referral program. In such cases, you are notified that you have been referred by an employee, but your contact information is not retained after sending you a notification email. Through the notification email, you will be asked to apply in our application management system. We have documented employee referral guidelines in place. Some information is generated automatically when you use or otherwise interact with our application management system to create an account and manage your job applications. In connection with your application for an open position, we may process the following personal information: contact and general identification information (e.g. name, preferred first name, last name, gender, ethnicity, disability, date and place of birth, nationality, email and/or postal address, fixed and/or mobile phone number, etc.); social media profile information (i.e. when you use your social media accounts to register in our application management system; your profile details such as name, email address, and other information that you choose to make accessible to us when you connect your social media account with our talent management system) family, hobbies, or interests (not mandatory and only as you deem necessary to share or voluntarily include in your CV/Resume); past remuneration and benefits data (such as salary level and amount, bonus, stocks, options, insurance, lost incentives, and other benefits in the countries where required and to the extent legally permitted); education, professional standing, and job preferences (such as employment and education history, professional qualifications, skills, college transcripts, letter of recommendation, certifications, and experience, past employers and their contact data, location preference, role preference (function and discipline), language preference, information necessary to complete a background check as required and legally permitted and other information you voluntarily provide in your CV/Resume/Cover letter) electronic identification and systems access data (e.g. picture or facial image, publicly available profiles on social media, online identifiers/cookies, user name, passwords, secret questions and answers, system login and activity logs, access and connection times, sound or video recordings such as remote conferencing platforms, on-site CCTV or voice recordings for security purposes); Only when legally permitted in your country, information pertaining to legal standing, credit, and background validations depending on the position’s responsibilities, information necessary to complete a background or credit or solvency check as well as judicial data and investigation data (e.g. proceedings, outcomes, information, documentation, and convictions). Please note that the performance of these checks will be dependent on several factors such as the position, as well as the local availability and viability of each AcedrA legal entity offering such a position. You will be provided with further details on this, should it be relevant to your application. Insofar as strictly necessary and legally permitted, your sensitive personal information will be collected only if you voluntarily allow for disclosure (such as visible or reported disabilities or protected group belonging, religion, diversity, and inclusion-related information, or labor union membership). More generally, We will process information that you voluntarily and willingly disclose mostly during interviews, and which should be strictly related to your professional capacity and fit for the corresponding open position. You may also join AcedrA Network by registering yourself by providing some of your personal information as listed above and stay connected with us for news, career opportunities specific to your background, and exclusive messages from our associates about what it is really like to work for us. If you join AcedrA Network, your personal information is processed to periodically send you career-related communications and you can anytime opt out if you wish to do so using the link provided in our communication emails to you. Our recruiters review job applications to determine the job fitment. Our recruitment processes are not based on automated decision-making. You may, at any point in time and without any repercussions, manage, update or delete your personal information directly through your account or indirectly by requesting to us. We are committed to honoring your privacy at all times. Just notify your interviewer, HR, or Talent Acquisition representative about your concerns. 2. For which purposes do we use your personal information and why is this justified? 2.1 Legal basis for the processing We will not process your personal information if we do not have a proper justification foreseen in the law for that purpose. Therefore, we will only process your personal information if: we have obtained your prior consent; the processing is necessary to perform our contractual obligations towards you and to take pre-contractual steps at your request; the processing is necessary to comply with our legal or regulatory obligations; the processing is necessary to protect your vital interests or those of another person; or the processing is necessary for our legitimate interests, which do not unduly 2.2 Purposes of the processing We always process your personal data for a specific purpose and only process the personal data which is relevant to achieve that purpose. In particular, we process your personal data for the following purpose(s): phone or electronic communications, including interviews in person or remotely; conduct cognitive tests or personality assessments or other suitability evaluations, fitted to the corresponding open position; perform background or employment checks (when applicable and legally permitted); verify your identity, academics, or qualifications in relation to your application; perform general analytics to improve our internal processes, as well as to provide a better service to you when applying for an open position with us; administer your application using internal or external recruitment platforms like job boards, as required under applicable law. 3. Who has access to your personal information and to whom your information is transferred? We will not sell, share, or otherwise transfer your personal data to recipients or third parties other than those indicated in this Privacy Policy. In the course of our activities and for the same purposes as those listed in this Notice, your personal data can be accessed by, or transferred to the following categories of recipients or third parties, on a need-to-know basis to achieve such purposes: our personnel (including personnel, departments, or other companies affiliated with or subsidiaries of AcedrA); our services providers that provide services and products to us; our IT systems providers, cloud service providers, database providers, and consultants; any third party to whom we assign or novate any of our rights or obligations; and our advisors and external lawyers in the context of the sale or transfer of any part of our business or its assets. The above third parties are contractually obliged to protect the confidentiality and security of your personal data, in compliance with applicable law. We may share personal data you submit as part of the application process with selected service providers or consultants acting on our behalf that may assist us in recruiting talent, performing data analysis, providing talent or application management systems, providing IT or related infrastructure, providing communication or reach out services, administering and evaluating pre-employment screening and testing, and improving our recruitment process. Your personal information can also be accessed by or transferred to any national and/or international regulatory, enforcement, public body, or court, where we are required to do so by applicable law or regulation or at their request. The personal information we collect from you may also be processed, accessed, or stored in a country outside the country where we are located, which may not offer the same level of protection of personal information. 4. How do we protect your personal information? We have implemented appropriate technical and organizational measures to provide an adequate level of security and confidentiality for your personal information. The purpose of these measures is to protect it against accidental or unlawful destruction or alteration, accidental loss, unauthorized disclosure or access, and against other unlawful forms of processing. 5. How long do we store your personal information? We will only retain your personal information for as long as necessary to fulfill the purpose for which it was collected or to comply with legal or regulatory requirements. The information you submit will be retained in the candidate database for a period of 12 months since you last updated your profile, or longer if you are still being considered for an open position, or if you have updated your candidate account (e.g. apply to another job, update your CV/Resume). Recruiters at AcedrA, AcedrA's subsidiaries, and affiliated companies will be able to access your Information and may contact you should a suitable opening arise. If your information is shared with us by a recruitment agency, and you have consented accordingly, the Information will be retained for a period of 24 months since submission, or longer if you have updated your account or you are being considered for an open position. Personal information collected and processed in the context of a dispute is deleted or archived (i) as soon as an amicable settlement has been reached, (ii) once a decision in last resort has been rendered, or (iii) when the claim becomes time-barred. 6. What are your rights and how can you exercise them? Whenever we process Personal information, we take reasonable steps to keep your Personal information accurate and up-to-date for the purposes for which they were collected. We will provide you with the ability to exercise the following rights under the conditions and within the limits set forth in the law. the right to be informed about what personal information we have about you and how we process your data the right to access your personal information as processed by us and, if you believe that any information relating to you is incorrect, obsolete or incomplete, to request its correction or updating; the right to request the erasure of your personal information or the restriction thereof to specific categories of processing; the right to withdraw your consent at any time, without affecting the lawfulness of the processing before such withdrawal; the right to object, in whole or in part, to the processing of your personal information. With certain exceptions, this includes the right to object to direct marketing and the right to object to your data being used for research.; and the right to request its portability, i.e. that the personal information you have provided to us be returned to you or transferred to the person of your choice, in a structured, commonly used and machine-readable format without hindrance from us and subject to your confidentiality obligations. the right to object to automated decision making including profiling, i.e. you can request human intervention in any automated decision-making process related to the processing of your data and where such processing is not based on your consent, authorized by law, or necessary for the performance of a contract. However, we don’t currently make decisions solely using automated processes If you have a question or want to exercise the above rights, you may send an email to our data protection officer at legal.affairs@acedrarx.com for application related to positions with us or send a letter to our local address with a scan of your identity card for identification purpose, it being understood that we shall only use such data to verify your identity and shall not retain the scan after completion of the verification. When sending us such a scan, you should make sure to redact your picture and national registry number or equivalent on the scan. If you are not satisfied with how we process your personal information, your may address your request to our data protection officer at legal.affairs@acedrarx.com who will investigate your concern. In any case, you also have the right to file a complaint with the competent data protection authorities, in addition to your rights above. 7. How will you be informed of the changes to our Privacy Notice? We may change or update this notice from time to time by posting a new privacy notice in our application management systems or our corporate website (https://www.acedrarx.com/privacy-cookies-policy ). Please keep checking this notice occasionally so that you are aware of any changes. Consent I confirm that I understand the above-stated and I agree to the processing of my personal information. By submitting my application, I hereby authorize and consent to the basic background checks during the selection process, where legally permitted and as required for the specific open position, on my personal information as outlined above. Such checks may be performed or conducted by the corresponding AcedrA legal entity’s authorized third parties. I agree that my personal information will also be used to perform extended background checks, to the extent permitted by law and where required, later at the time of an employment offer by AcedrA when an extended background check notice will be provided to me. Agree Decline

AcedrA is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, national origin, social status or disability status. Application Form General Information Section First Name Last Name Code Phone Street Address Street Address Line 2 City Region/State/Province Postal / Zip code Country Country Birthday Email How did you hear about us Choose an option Work Experience Section Total Years of Experience - Excluding Internships & Volunteering Years of Experience Actual / Last Position Start from Actual / Last Company Name End in Location Still on Job Role Description Education Section Main / Last Degree Specialty / Field of Study School / College / University Name Start from End in (Actual / Expected) Skills Section Hard & Soft Skills Languages Arabic English French Others Attachement Upload your updated Resume Upload Resume Upload supported file (Max 15MB) PSD, MS Wordd Link to your Xing or LinkedIn Profile Consent & Submission I hereby Confirm that the information given in this application are correct and accurate. Your Signature Clear Please Note: After you submit your application you will not be able to edit/update this section. So please ensure you have everything attached before completing your application. Submit Thank you! We’ll be in touch. Back to Vacancies Back to Home

Acedra is a company dedicated to improving the lives of people everywhere. We strive to meet both unmet medical needs and unmet commercial needs through our three business units: Unmet Medical Needs, Unmet Commercial Needs, and Medical Technology. Business Units At AcedrA, we understand the value of strategic business units and their ability to create synergy within a business. That's why our business is organized into three distinct business units: Unmet Commercial Needs, Unmet Medical Needs, and Medical Technology. By utilizing business units, we enable cross-functional collaboration between departments and foster an environment of innovation and creativity that can help meet business goals. Our business units allow us to focus on specific areas of therapeutics, develop unique solutions, and create greater value for the patients' communities and scientific societies. As we continue to grow and evolve as a business, it's important that we stay focused on strategic business units in order to maximize our potential. We believe that the business units we have created will help us to create a more innovative and successful business. We are excited to continue our journey forward with business units at AcedrA and remain confident in our ability to move the business forward. With strategic business units, we are ready to take on any challenge and confidently move forward toward success. At AcedrA, business units are the foundation of our business and embody our commitment to crafting innovative solutions for our customers. As we move forward, we look forward to continuing to leverage business units in order to create greater value for all stakeholders. Together, let's build something great! Unmet Medical Needs We have a team of dedicated, passionate professionals who are working to revolutionize the process of making groundbreaking treatments available to patients with unmet medical needs, they take pride in their innovative approach to identifying diseases with no existing treatment options or with low alternatives and bridging with novel solutions to serve those populations. Discover Unmet Commercial Needs At AcedrA, we believe that all patients should have access to the best possible care available. That's why our team is dedicated to finding new and innovative ways to make treatments more accessible and affordable. By exploring existing methods of care, we are committed to providing solutions that benefit both patients and providers alike. Discover Medical Technology At AcedrA Medical Technology Business Unit, we are revolutionizing care with cutting-edge products and services. Our team of experts is using innovative solutions to drive advances in patient care while reducing healthcare costs. We believe that with the right technology, anything is possible. Discover Si vous avez des commentaires sur la gouvernance d'AcedrA, laissez-nous un message et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Partnership Access Sourcing

Non-Discrimination Notice Our responsibilities: We follow Saudi Arabia's Human Rights laws. We do not discriminate on the basis of race, color, national origin, age, disability, or sex. We do not exclude people or treat them differently because of their race, color, national origin, age, disability, or sex. We help people with disabilities to communicate with us. This help is free. It includes: Qualified sign language interpreters Written information in other formats, such as large print, audio, and accessible electronic formats We provide services for people who do not speak Arabic or English or who are not comfortable speaking Arabic or English. These services are free. They include: Qualified interpreters Information is written in other languages For language or communication hel p: Call Toll-Free at 8001240411 if you need language or other communication help. If you have questions about our non-discrimination policy: Contact the Compliance Department at +966 11 400 0036 or compliance@acedrarx.com To file a grievance: If you believe that we have not provided these services or have discriminated against you because of your race, color, national origin, age, disability, or sex, you can file a grievance by contacting the Human Resources Department or the Compliance Department at +966 11 400 0036 , human.resources@acedrarx.com , compliance@acedrarx.com You can also file a civil rights complaint with the Ministry of Human Resources and Social Development (MHRSD) , and the Saudi Human Rights Commission .

Invest Our innovative solutions are designed to make a real impact on patients' care and lives. Investing in our solutions means you're investing in a brighter, healthier future for everyone. Be part of our Mission AcedrA is an innovative company focused on providing access to cutting-edge therapeutics for improving patient lives. Investing in AcedrA means investing in the future of healthcare and helping create a better world. Our team of experts is devoted to developing solutions with the potential to be game-changers in medical treatment habits in the MENA region, making your investment a sound one. Invest in AcedrA and help us bring our mission of improving patients' life by accessing innovative therapeutics to life, improving the lives of patients around the world. Invest in the future today. Invest in AcedrA. Contact us to learn more about our mission and how to become part of it. We look forward to hearing from you! Invest in the Future Read More Si vous avez des commentaires sur la gouvernance d'AcedrA, laissez-nous un message et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! AcedrA Institute Invest in the Future

Message du PDG Depuis la création d'AcedrA en 2017, nous suivons la règle du « oser faire » dans l'élaboration de nos processus et de nos plans. Nous avons toujours prouvé notre passion pour la science, et c'est dans notre ADN de créer une nouvelle valeur en transformant la façon dont nous aidons les patients et les communautés scientifiques dans cette partie du monde où il existe un écart hétérogène dans la couverture des besoins non satisfaits. Nous avons établi un nouveau modèle d'entreprise qui exige de faire du patient le principal pilier de la formulation d'objectifs d'entreprise durables. Nous avons eu l'audace de prouver notre capacité à servir la communauté scientifique et médicale en créant une plateforme hybride reliant la communauté académique, les entreprises de R&D, les hôpitaux et le patient. Notre présence au Royaume d'Arabie saoudite et notre alignement sur les objectifs de Vision 2030 ont contribué de manière significative à attirer les dernières découvertes scientifiques en termes de solutions pharmacologiques et médicales aux patients et aux communautés scientifiques et ont renforcé notre rôle dans la réduction de l'impact des problèmes non satisfaits. Besoins. Cela nous a aidés à étendre nos activités dans toute la région du Moyen-Orient et de l'Afrique du Nord, car toutes les frontières sont supprimées de la prise en charge de la santé humaine. Et d'opérer dans les nouveaux domaines de la biotechnologie et de l'édition de gènes. Un grand merci du fond du cœur à tous nos collaborateurs, partenaires, bailleurs de fonds, clients. Chaque minute dans l'entreprise est une histoire inspirante pour nous tous sur le dévouement à fournir le meilleur de ce que nous avons pour servir la vision importante et noble. Et la marche continue… vers le succès. Mohamed Hosni STA Fondateur & PDG Al Riyad, Arabie Saoudite 12 janvier 2023 Executive Team Services

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Commercial Structure The commercial team at AcedrA is a crucial part of the organization. We understand the importance of meeting our pharmaceutical partner's needs and exceeding their expectations. Our team strives to provide world-class service, leveraging innovative technology and best practices to ensure success for everyone involved. We are able to identify key trends and insights that help drive product sales and increase customer satisfaction. Furthermore, our experienced team of professionals is dedicated to understanding their customers' needs and providing unique solutions tailored specifically for each situation. Our commercial team puts forth their best effort to ensure excellence in every step of the process - from creating innovative marketing strategies to delivering superior customer service. Partner with Us +1,600 Operations executed and delivered to the hospitals in 2 continents +30,000,000 of Pharmaceutical and Medical units distributed till today Key Components of our Excellence Commercial excellence is defined as a strategic approach that combines market insights, customer data and analytics, sales force effectiveness, and pricing strategies. In the pharmaceutical sector, these activities are essential for improving product launch and portfolio performance. Excell in Sales & Marketing We provide sales & marketing services to pharma & medical companies, helping them to develop state-of-the-art strategies that will help them increase their market presence. Our experienced team of specialists is knowledgeable in the industry, giving us a unique insight into current trends and technologies. Discover Excell in CRM Our CRM services enable pharmaceutical and medical companies to develop long-term relationships with their customers. By integrating the latest technology into our solutions, we provide a platform that brings together all aspects of customer relationship management needs. Discover Excell in Data Analytics AcedrA's data analytics system is a powerful tool that provides our partners with invaluable insights into their operations. Our platform offers real-time reporting of key performance indicators (KPIs), giving users the ability to quickly assess their operations and identify areas for improvement. Discover Key Outcomes of our Excellence Overall, our commercial excellence activities are your key success factor to remain competitive in today's marketplace. By leveraging market insights, optimizing your sales force effectiveness, and developing strategic Market Insights Market insights allow our partners to gain a better understanding of the dynamics and trends in their markets. By collecting data on customer behaviors, we can develop more effective marketing and sales strategies. Partner with Us Sales Force Effectiveness We ensure that your sales force is properly trained and equipped with the necessary tools to effectively market and sell your products. This includes providing educational materials, setting goals for sales team members, and developing incentives for meeting those goals. Partner with Us Pricing Strategies We determine how much we can charge for your products without pricing themselves out of the market. This requires a thorough understanding of market dynamics, customer preferences, and competitive landscape, as well as a deep knowledge of pricing strategies. Partner with Us +160 Customers With over 160 hospitals in its network, AcedrA is committed to providing outstanding healthcare solutions that go beyond patient satisfaction – they're built for life-saving excellence. Connecting with AcedrA means having access to the best medical professionals and facilities in the region, enabling you to drive your healthcare system to new heights. Put your trust in AcedrA – experienced, reliable, and dedicated to your care. +40,000 Patien ts AcedrA's commitment to helping people reach their health goals has spread far and wide, with over 40,000 patients from two continents enjoying the relief they found in our medication and products. With a passion for improving lives, AcedrA is proud to have become a trusted resource for many around the world. We look forward to continuing to provide our expertise and quality care to people in need. Experience the difference with AcedrA today! The National Unified Procurement Company Johns Hopkins Healthcare Aramco King Fahd Medical City Cleveland Clinic Abu Dhabi Saudi Ministry of Health NEOM King Faisal Specialist Hospital & Research Center Ministry of Health Tunisia King Khaled Eye Specialist Hospital The American Hospital King Saud Univesrity WASFATY King Abdullah Bin Abdulaziz University Hospital King Abdullah Medical City Ministry of National Guard Health Affairs SEHA Abu Dhabi King Fahd Specialist Hospital Dammam Ministry of Defence Business Support Partnership

Titre de la page Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Section titre Chaque site Web a une histoire et vos visiteurs veulent entendre la vôtre. Cet espace est une excellente occasion de donner un aperçu complet de qui vous êtes, de ce que fait votre équipe et de ce que votre site a à offrir. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez que les visiteurs du site connaissent. Si vous êtes une entreprise, parlez de vos débuts et partagez votre parcours professionnel. Expliquez vos valeurs fondamentales, votre engagement envers les clients et comment vous vous démarquez de la foule. Ajoutez une photo, une galerie ou une vidéo pour encore plus d'engagement. Reports & Presentations Be AcedrAian

APPEL À TOUS LES MÉDIAS Tout ce que tu as besoin de savoir BIOS ET ENTREVUES Convient à tous les médias VIDÉOS DE DÉMO Rendez-le visuel IMAGES ET ICÔNES Les informations dont vous avez besoin Maladies rares et ultra-rares Apprendre encore plus Access Innovation Business Development